Michele Park

PhD, Partner at NEA

Michele is a Partner at NEA on the Healthcare team focused on the biopharma space. Prior to NEA, Michele was an investor at Clarus Ventures (now Blackstone Life Sciences). Previously, she spent time in biotechnology research analyst roles at Credit Suisse and Piper Jaffray. Michele received her PhD in Molecular Biology from Weill Cornell Graduate School of Medical Sciences and completed her dissertation at Memorial Sloan Kettering Cancer Center. She holds a BA in Molecular Biology from Princeton.